AIM: To systematically review and Meta-analyze studies of managing open angle glaucoma (OAG) with gonioscopy-assisted transluminal trabeculotomy (GATT) and to evaluate its effectiveness and safety. METHODS: Eligible studies were retrieved and screened from five main electronic databases. Mean difference (MD) was hired to show the pooled effectiveness of intraocular pressure (IOP) and medication decrease achieved by GATT. In addition, combined surgical success and reoperation rates were calculated, and complications were also summarized. RESULTS: Ten studies were included for systematic review, but one study was not pooled for Meta-analysis due to the repeated data. The combined IOP decrease after GATT was 9.81 mm Hg (95%CI: 7.98-11.63 mm Hg) which showed significant reduction from the baselines (Z=10.52, P<0.0001). Similarly, the number of medications after GATT also decreased distinctly compared with that of medication before the surgery (Z=9.09, P<0.0001), and the pooled medication decrease was 1.68 (95%CI: 1.31-2.04). In addition, the combined surgical success rate was 85%, while the pooled reoperation rate was 20%. Sight-threatening complications occurred scarcely, whereas the pooled occurrence rate of hyphemia was as high as 36.0%. CONCLUSION: GATT could effectively lower IOP and decrease medications for patients with OAG. Moreover, the procedure appears to be a safe and promising treatment for OAG due to its minimally-invasive and conjunctiva-sparing nature. International Journal of Ophthalmology Press.
AIM: To systematically review and Meta-analyze studies of managing open angle glaucoma (OAG) with gonioscopy-assisted transluminal trabeculotomy (GATT) and to evaluate its effectiveness and safety. METHODS: Eligible studies were retrieved and screened from five main electronic databases. Mean difference (MD) was hired to show the pooled effectiveness of intraocular pressure (IOP) and medication decrease achieved by GATT. In addition, combined surgical success and reoperation rates were calculated, and complications were also summarized. RESULTS: Ten studies were included for systematic review, but one study was not pooled for Meta-analysis due to the repeated data. The combined IOP decrease after GATT was 9.81 mm Hg (95%CI: 7.98-11.63 mm Hg) which showed significant reduction from the baselines (Z=10.52, P<0.0001). Similarly, the number of medications after GATT also decreased distinctly compared with that of medication before the surgery (Z=9.09, P<0.0001), and the pooled medication decrease was 1.68 (95%CI: 1.31-2.04). In addition, the combined surgical success rate was 85%, while the pooled reoperation rate was 20%. Sight-threatening complications occurred scarcely, whereas the pooled occurrence rate of hyphemia was as high as 36.0%. CONCLUSION: GATT could effectively lower IOP and decrease medications for patients with OAG. Moreover, the procedure appears to be a safe and promising treatment for OAG due to its minimally-invasive and conjunctiva-sparing nature. International Journal of Ophthalmology Press.
Authors: Davinder S Grover; David G Godfrey; Oluwatosin Smith; William J Feuer; Ildamaris Montes de Oca; Ronald L Fellman Journal: Ophthalmology Date: 2014-01-10 Impact factor: 12.079
Authors: Maria E Lim; Daniel E Neely; Jingyun Wang; Kathryn M Haider; Heather A Smith; David A Plager Journal: J AAPOS Date: 2015-04 Impact factor: 1.220
Authors: Davinder S Grover; David G Godfrey; Oluwatosin Smith; Wei Shi; William J Feuer; Ronald L Fellman Journal: J Glaucoma Date: 2017-01 Impact factor: 2.503
Authors: Davinder S Grover; Oluwatosin Smith; Ronald L Fellman; David G Godfrey; Aditi Gupta; Ildamaris Montes de Oca; William J Feuer Journal: J Glaucoma Date: 2018-05 Impact factor: 2.503
Authors: Eamon Sharkawi; Paul H Artes; Daniel Josef Lindegger; Maria Laura Dari; Mohamad El Wardani; Jérôme Pasquier; Adriano Guarnieri Journal: Graefes Arch Clin Exp Ophthalmol Date: 2021-06-22 Impact factor: 3.117